Dr. Stephan Rau ist auf Zusammenschlüsse und Übernahmen im Gesundheits- und Life-Science-Sektor, Medizin- und Gesundheitsrecht, einschließlich universitärer Einrichtungen, und der damit zusammenhängenden Compliance spezialisiert. Er ist Mitglied der deutschen Praxisgruppe für Gesellschaftsrecht/M&A und leitet die europäische Praxisgruppe der Kanzlei für den Bereich Gesundheitswesen, Life Sciences und Medizintechnik.
2004 beriet Dr. Rau bei der Gründung der ersten deutschen MVZ-GmbH. Seitdem hat er zahlreiche Investoren, Gesundheitsdienstleister, Pharma-Konzerne, Medizinproduktehersteller und staatliche Einrichtungen bei M&A-Transaktionen, Outsourcing-Projekten sowie bei Zulassungs- und Rückerstattungsverfahren vertreten.
Dr. Rau referiert regelmäßig auf Konferenzen der Gesundheitsbranche und ist Autor zahlreicher Publikationen zum deutschen Gesellschafts- und Kartellrecht, zu Gesundheits- und Life-Science-Regulierungen sowie zum russischen Privatisierungs- und Kartellrecht. Vor seiner Zeit bei McDermott arbeitete Dr. Rau für internationale Kanzleien in Moskau, Hamburg und Berlin. Er ist vereidigter Dolmetscher und Übersetzer für Russisch.
Ausbildung
Humboldt-Universität Berlin, Dr. jur., 2003
Kammergericht, Berlin, Zweites Staatsexamen, 1998
Universität Heidelberg, Erstes Staatsexamen, 1996
Universität Paris-Dauphine, Maîtrise en Économie Appliquée, 1994
London School of Economics and Political Science, Master of Science in Government, 1993
IHK Wiesbaden, Dolmetscher und Übersetzer für Russisch, 1990
Zulassungen
Deutschland
GerichtshÖFe/BehÖRden
Alle Gerichte und Oberlandesgerichte in Deutschland
Sprachen
Englisch
Deutsch
Französisch
Russisch
Partner | München
Munich: +49 89 12712 322
Munich: +49 89 12712 117
Shanghai, China / McDermott Event / November 12, 2019
London, United Kingdom / McDermott Event / September 26, 2019
On the Subject / April 2019
Berlin, Germany / McDermott Event / February 27, 2019
London, United Kingdom / McDermott Event / October 4, 2018
Munich, Germany / McDermott Event / September 25, 2018
Copenhagen, Denmark / McDermott Event / June 13, 2018
Copenhagen, Denmark / Speaking Engagements / June 12, 2018
Copenhagen, Denmark / Speaking Engagements / June 11, 2018
Shanghai, China / McDermott Event / November 16, 2017
Munich, Germany / McDermott Event / September 19, 2017
London, United Kingdom / McDermott Event / June 28, 2017
San Francisco, California / McDermott Event / January 10, 2017
On the Subject / November 21, 2016
On the Subject / 28. Juni 2016
UnternehmerEdition "Health“, Issue 4 / October 2015
Telemedicine in Germany - What Legal Changes Are Needed and What Are ...
PharmaRecht, Issue 4 / April 30, 2015
Comparable Drugs in Price Negotiations Under Sec. 130b SGB V
Pharmind, Issue 11 / November 2014
New Developments On Combating Corruption and Compliance In Healthcare
International Law Office Newsletter, Germany / October 29, 2014
German Perspective on New EU Clinical Trials Regulation
Tokyo, Japan / Diversity Event / October 22, 2014
On the Subject / October 20, 2014
Munich, Germany / Diversity Event / September 24, 2014
International Law Office Newsletter, Germany / June 18, 2014
Pricing for New Innovative Drugs – Public Payers Attempt New Approach
VC Magazine / April 23, 2014
Legal Framework for Health Apps
International Law Office Newsletter, Germany / February 26, 2014
Generic Drug and API Producers Deal with the Bolar Exemption
International Law Office Newsletter, Germany / February 19, 2014
Yet another Health Reform and Seizure of Retiring Doctors' Practices
Healthcare Marketing - Das Fachmagazin für Gesundheitsmarken, Issue 1-2 / January 2014
Patent Expirations: Generic Drugs and Active Ingredient Producers from the Perspective of ...
1
2
3
4
5
Global Legal Chronicle / November 19, 2019
United Homecare Partners’ Acquisition of German and Austrian Nursing Healthcare at Home ...
RWS Verlag / November 4, 2019
McDermott Advises Healthcare at Home on the Sale of German and Austrian ...
München / Press Releases / November 4, 2019
McDermott berät Healthcare at Home beim Verkauf deutscher und österreichischer Pflegebetriebe ...
München / Press Releases / October 30, 2019
Healthcare Business International / October 31, 2019
London / Press Releases / September 18, 2019
McDermott to Host European Healthcare Private Equity Leadership Forum 2019
London / Accolades & Rankings / March 18, 2019
Düsseldorf / Accolades & Rankings / December 4, 2018
McDermott Continues to Showcase Innovative Client Service and Strategic Growth as Top 25 ...
Düsseldorf / Best Lawyers® / June 28, 2018
Düsseldorf / Accolades & Rankings / March 9, 2018
McDermott Again Ranked as a Leading Law Firm By Chambers Europe
München / Coverage / 3. Oktober 2017
München / Global Legal Chronicle / July 31, 2017
Eurofins Scientific SE’s Acquisition of MVZ für Laboratoriumsmedizin of Hygel
Brüssel / Press Releases / June 30, 2017
Düsseldorf / Accolades & Rankings / April 18, 2017
McDermott Recommended in Legal 500 EMEA 2017 and Top-Tier Ranked in France for Healthcare ...
Düsseldorf / Accolades & Rankings / April 10, 2017
Düsseldorf / Press Releases / January 6, 2017
McDermott Maintains Strong Rankings in The Legal 500 Deutschland 2017
München / Juve (Germany) / September 25, 2016
In-Pharma Technologist / August 1, 2016
AstraZeneca: Retaining Current Regulatory Procedures Crucial, Post-Brexit
London / In-Pharma Technologist / July 27, 2016
GSK Commits to UK Manufacturing with £275m Investments Across Three Sites
Pharmaceutical Processing / July 22, 2016
The Events Leading to the Brexit & What It Means for Pharma’s ...
London / Drug Discovery News / July 2016
IBA [International Bar Association] Global Insight / April 12, 2016
JUVE (Germany) / June 29, 2015
Laboratory Services: Cinven Works with Clifford to Buy Synlab for 1.2 Billion Euros
Düsseldorf / Accolades & Rankings / May 5, 2015
McDermott European Practice Shows Continuous Growth in Ranking Results in Chambers Europe 2015
1
2
3
4
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
